These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4075360)

  • 1. From theory to therapy: how to make a new drug out of a new idea.
    Beyer KH
    Clin Ther; 1985; 7(6):652-8. PubMed ID: 4075360
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of patent term restoration to pharmaceutical innovation.
    Hutt PB
    Health Aff (Millwood); 1982; 1(2):6-24. PubMed ID: 7185724
    [No Abstract]   [Full Text] [Related]  

  • 3. Prologue: chirality in the pharmaceutical industry.
    Caldwell J; Berova N; McConnell O
    Chirality; 2007 Sep; 19(9):657. PubMed ID: 17657706
    [No Abstract]   [Full Text] [Related]  

  • 4. Break with tradition.
    Jayaraman KS
    Nature; 2006 Jul; 442(7101):342-3. PubMed ID: 16871181
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical excipient development: the need for preclinical guidance.
    Baldrick P
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulating the right chemistry.
    Trivedi B
    Nat Biotechnol; 1999 Apr; 17(4):339-41. PubMed ID: 10207880
    [No Abstract]   [Full Text] [Related]  

  • 8. Expanding the scope of crystal form evaluation in pharmaceutical science.
    Peterson ML; Hickey MB; Zaworotko MJ; Almarsson O
    J Pharm Pharm Sci; 2006; 9(3):317-26. PubMed ID: 17207415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure elucidation and reaction monitoring of synthetic intermediates using an automated accurate mass GC-TOF mass spectrometer in drug discovery.
    Petucci C; Woodworth R; Hauze D
    J Mass Spectrom; 2005 Oct; 40(10):1387-9. PubMed ID: 16220523
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of combinatorial chemistry science on modern drug discovery.
    Kennedy JP; Williams L; Bridges TM; Daniels RN; Weaver D; Lindsley CW
    J Comb Chem; 2008; 10(3):345-54. PubMed ID: 18220367
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examples of NIR based real time release in tablet manufacturing.
    Skibsted ET; Westerhuis JA; Smilde AK; Witte DT
    J Pharm Biomed Anal; 2007 Mar; 43(4):1297-305. PubMed ID: 17166686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategic use of preparative chiral chromatography for the synthesis of a preclinical pharmaceutical candidate.
    Leonard WR; Henderson DW; Miller RA; Spencer GA; Sudah OS; Biba M; Welch CJ
    Chirality; 2007 Sep; 19(9):693-700. PubMed ID: 17354260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of basic principles of fractals and their application to pharmacokinetics.
    Marsh RE; Riauka TA; McQuarrie SA
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):278-88. PubMed ID: 18551095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New uses for old drugs.
    Chong CR; Sullivan DJ
    Nature; 2007 Aug; 448(7154):645-6. PubMed ID: 17687303
    [No Abstract]   [Full Text] [Related]  

  • 17. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
    Schirlin D; Galvan M; Le Fur G
    Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragment-based lead discovery.
    Rees DC; Congreve M; Murray CW; Carr R
    Nat Rev Drug Discov; 2004 Aug; 3(8):660-72. PubMed ID: 15286733
    [No Abstract]   [Full Text] [Related]  

  • 19. Formula optimization based on neural networksin sustained release tablets.
    Wei X; Liang W
    Pharmazie; 2003 Jul; 58(7):521-2. PubMed ID: 12889541
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation of a multi-antioxidant formulation.
    Mulnix JA; Stoddard BE
    Methods Mol Biol; 2008; 477():321-8. PubMed ID: 19082957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.